E-LIB Suche - Ergebnisse für: Johnson, Melissa L

1

Vertical and temporal flight patterns of coffee berry borer..:

Johnson, Melissa A ; Maeda, Colby T ; Pulakkatu-Thodi, Ishakh.
Environmental Entomology. , 2024

2

Consensus recommendations for the use of novel antiretrovir..:

Cluck, David B. ; Chastain, Daniel B. ; Murray, Milena...
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 44 (2024) 5 - p. 360-382 , 2024

Link: https://doi.org/10.1002/..

3

Exploring the biopsychosocial impact of hypermobility spect..:

Clark, Natalie L. ; Johnson, Melissa ; Rangan, Amar..
Systematic Reviews. 13 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

4

Safety, pharmacokinetics, pharmacodynamics, and antitumor a..:

Baranda, Joaquina C. ; Robbrecht, Debbie ; Sullivan, Ryan...
Clinical and Translational Science. 17 (2024) 6 - p. , 2024

Link: https://doi.org/10.1111/..

5

Dual-Modified Hyaluronic Acid for Tunable Double Cross-Link..:

Milne, Cameron ; Song, Rijian ; Johnson, Melissa...
Biomacromolecules. 25 (2024) 4 - p. 2645-2655 , 2024

Link: https://doi.org/10.1021/..

6

Identifying MAGE-A4-positive tumors for TCR T cell therapie..:

Wang, Tianjiao ; Navenot, Jean-Marc ; Rafail, Stavros...
Molecular Therapy - Methods & Clinical Development. 32 (2024) 2 - p. 101265 , 2024

Link: https://doi.org/10.1016/..

7

A Brief Report of Durvalumab With or Without Tremelimumab i..:

Garon, Edward B. ; Cho, Byoung Chul ; Luft, Alexander...
Clinical Lung Cancer. 25 (2024) 3 - p. 266-273.e5 , 2024

Link: https://doi.org/10.1016/..

8

Biomarker-directed targeted therapy plus durvalumab in adva..:

Besse, Benjamin ; Pons-Tostivint, Elvire ; Park, Keunchil...
Nature Medicine. 30 (2024) 3 - p. 716-729 , 2024

Link: https://doi.org/10.1038/..

9

Anti-TIGIT antibody improves PD-L1 blockade through myeloid..:

Guan, Xiangnan ; Hu, Ruozhen ; Choi, Yoonha...
Nature. 627 (2024) 8004 - p. 646-655 , 2024

Link: https://doi.org/10.1038/..

10

Results of a Randomized, Double-Blind, Placebo-Controlled, ..:

Gardner, Faithlore P. ; Wainberg, Zev A. ; Fountzilas, Christos...
Cancers. 16 (2024) 7 - p. 1323 , 2024

Link: https://doi.org/10.3390/..

11

PP01.24 FURVENT: Phase 3 trial testing furmonertinib vs che..:

Spira, Alexander ; Cho, Byoung Chul ; Felip, Enriqueta...
Journal of Thoracic Oncology. 19 (2024) 7 - p. e17-e18 , 2024

Link: https://doi.org/10.1016/..

12

Smart biodegradable hydrogels: Drug-delivery platforms for ..:

Aragón-Navas, Alba ; López-Cano, José Javier ; Johnson, Melissa...
International Journal of Pharmaceutics. 649 (2024) - p. 123653 , 2024

Link: https://doi.org/10.1016/..

13

Publisher Correction: Anti-TIGIT antibody improves PD-L1 bl..:

Guan, Xiangnan ; Hu, Ruozhen ; Choi, Yoonha...
Nature. 630 (2024) 8016 - p. E9-E9 , 2024

Link: https://doi.org/10.1038/..

14

Hyaluronic Acid/Chondroitin Sulfate-Based Dynamic Thiol–Ald..:

Johnson, Melissa ; Song, Rijian ; Li, Yinghao...
Materials. 17 (2024) 12 - p. 3003 , 2024

Link: https://doi.org/10.3390/..

15

The importance of pharmacist engagement in diagnostic stewa..:

Claeys, Kimberly C. ; Morgan, Daniel J. ; Johnson, Melissa D.
Antimicrobial Stewardship & Healthcare Epidemiology. 4 (2024) 1 - p. , 2024

Link: https://doi.org/10.1017/..